Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH

Boron neutron capture therapy (BNCT) is an experimental, binary treatment for brain cancer which requires as the first step that tumor tissue is targeted with a boron-10 containing compound. Subsequent exposure to a thermal neutron flux results in destructive, short range nuclear reaction within 10...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics. - 1993. - 62(2000), 1 Pt B vom: 27. Juli, Seite 1110-8
1. Verfasser: Gilbert, B (VerfasserIn)
Weitere Verfasser: Perfetti, L, Fauchoux, O, Redondo, J, Baudat, P A, Andres, R, Neumann, M, Steen, S, Gabel, D, Mercanti, D, Ciotti, M T, Perfetti, P, Margaritondo, G, De Stasio, G
Format: Aufsatz
Sprache:English
Veröffentlicht: 2000
Zugriff auf das übergeordnete Werk:Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Borohydrides Boron Compounds Sulfhydryl Compounds mercaptoundecahydrododecaborate 12294-22-3 boron oxide 483W67CPF4 mehr... Sulfur 70FD1KFU70 Boron N9E3X5056Q
LEADER 01000caa a22002652 4500
001 NLM110040309
003 DE-627
005 20250202085615.0
007 tu
008 231222s2000 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0367.xml 
035 |a (DE-627)NLM110040309 
035 |a (NLM)11088567 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Gilbert, B  |e verfasserin  |4 aut 
245 1 0 |a Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH 
264 1 |c 2000 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 08.01.2001 
500 |a Date Revised 28.07.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Boron neutron capture therapy (BNCT) is an experimental, binary treatment for brain cancer which requires as the first step that tumor tissue is targeted with a boron-10 containing compound. Subsequent exposure to a thermal neutron flux results in destructive, short range nuclear reaction within 10 microm of the boron compound. The success of the therapy requires than the BNCT agents be well localized in tumor, rather than healthy tissue. The MEPHISTO spectromicroscope, which performs microchemical analysis by x-ray absorption near edge structure (XANES) spectroscopy from microscopic areas, has been used to study the distribution of trace quantities of boron in human brain cancer tissues surgically removed from patients first administered with the compound Na2B12H11SH (BSH). The interpretation of XANES spectra is complicated by interference from physiologically present sulfur and phosphorus, which contribute structure in the same energy range as boron. We addressed this problem with the present extensive set of spectra from S, B, and P in relevant compounds. We demonstrate that a linear combination of sulfate, phosphate and BSH XANES can be used to reproduce the spectra acquired on boron-treated human brain tumor tissues. We analyzed human glioblastoma tissue from two patients administered and one not administered with BSH. As well as weak signals attributed to BSH, x-ray absorption spectra acquired from tissue samples detected boron in a reduced chemical state with respect to boron in BSH. This chemical state was characterized by a sharp absorption peak at 188.3 eV. Complementary studies on BSH reference samples were not able to reproduce this chemical state of boron, indicating that it is not an artifact produced during sample preparation or x-ray exposure. These data demonstrate that the chemical state of BSH may be altered by in vivo metabolism 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Research Support, U.S. Gov't, Non-P.H.S. 
650 7 |a Borohydrides  |2 NLM 
650 7 |a Boron Compounds  |2 NLM 
650 7 |a Sulfhydryl Compounds  |2 NLM 
650 7 |a mercaptoundecahydrododecaborate  |2 NLM 
650 7 |a 12294-22-3  |2 NLM 
650 7 |a boron oxide  |2 NLM 
650 7 |a 483W67CPF4  |2 NLM 
650 7 |a Sulfur  |2 NLM 
650 7 |a 70FD1KFU70  |2 NLM 
650 7 |a Boron  |2 NLM 
650 7 |a N9E3X5056Q  |2 NLM 
700 1 |a Perfetti, L  |e verfasserin  |4 aut 
700 1 |a Fauchoux, O  |e verfasserin  |4 aut 
700 1 |a Redondo, J  |e verfasserin  |4 aut 
700 1 |a Baudat, P A  |e verfasserin  |4 aut 
700 1 |a Andres, R  |e verfasserin  |4 aut 
700 1 |a Neumann, M  |e verfasserin  |4 aut 
700 1 |a Steen, S  |e verfasserin  |4 aut 
700 1 |a Gabel, D  |e verfasserin  |4 aut 
700 1 |a Mercanti, D  |e verfasserin  |4 aut 
700 1 |a Ciotti, M T  |e verfasserin  |4 aut 
700 1 |a Perfetti, P  |e verfasserin  |4 aut 
700 1 |a Margaritondo, G  |e verfasserin  |4 aut 
700 1 |a De Stasio, G  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics  |d 1993  |g 62(2000), 1 Pt B vom: 27. Juli, Seite 1110-8  |w (DE-627)NLM098226002  |x 1063-651X  |7 nnns 
773 1 8 |g volume:62  |g year:2000  |g number:1 Pt B  |g day:27  |g month:07  |g pages:1110-8 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 62  |j 2000  |e 1 Pt B  |b 27  |c 07  |h 1110-8